Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-25 @ 4:35 PM
NCT ID:
NCT06307457
Pre Assignment Details:
Data collected retrospectively from 1 January 2017 to 1 February 2024 from Danish Breast Cancer Group (DBCG) registry and was evaluated for approximately 1.3 months (duration from start of the study to end of the study) in this retrospective study.
Recruitment Details:
Participants diagnosed with hormone receptor positive (HR+) or human epidermal growth factor receptor (HER2) metastatic breast cancer (mBC) who initiated treatment with palbociclib in combination with aromatase inhibitor (AI) as first line treatment between 1 January 2017 to 31 December 2021 were observed.
Study:
NCT06307457
Study Brief:
Results Section:
NCT06307457